Figure 6.
Eradication of BLI evident OV-CAR3(MUC-CD) tumors in SCID-Beige mice by ip infusion of 4H11-28z+ T cells. (A) BLI of 4H11-28z+ T cell treated mice with either relapsed disease (middle row) or eradicated disease (bottom row) compared to a representative 19-28z+ T cell treated control mouse. (B) Kaplan-Meier survival curve of SCID-Beige mice with advanced OV-CAR3(MUC-CD/GFP-FFLuc) tumors treated i.p. with 4H11-28z+ T cells.